Summary
Between 1982 and 1986 51 patients were treated with ciclosporin a (CSA) to prevent graft versus host disease (GvHD) after bone marrow transplantation (BMT). Major side effects of the drug were tremor, hypertension, hepatotoxicity and nephrotoxicity. Acute GvHD 0° to II° occurred in 80% of our patients, and GvHD III° and IV° in 20% despite the use of CSA. Two to four days before the onset of GvHD, CSA serum levels were significantly lower on the average in patients who developed GvHD III° and IV° compared to the others. Our data indicate that plasma CSA concentrations higher than 250 ng/ml should be achieved to reduce the severity of GvHD after BMT.
This is a preview of subscription content, log in via an institution to check access.
References
Borel JF, Feurer C, Gubler HU, Staehelin H (1976) Biological effects of Cyclosporin A: A new antilymphocytic agent. Agents Actions 6: 468–475
Donatsch P, Abisch E, Homberger M, Traber R, Trapp M, Voges R (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2: 19–32
Einsele H, Ehninger G, Schneider EM, Krüger GFR, Vallbracht A, Dopfer R, Schmidt H, Waller HD, Müller CA (1987) High frequency of graft-versus-host-reactivity (GVHR) like syndromes following syngeneic bone marrow transplantation as sign of inappropriately controlled autoimmunity. Transplantation 45: 579–585
Gratwohl A, Speck B (1986) Bone marrow transplantation with ciclosporin. Prog Allergy 38: 404–431
Gratwohl A, Speck B, Wenk M, Forster I, Müller M, Osterwalder B, Nissen C, Follath F (1983) Cyclosporine in human bone marrow transplantation. Transplantation 36: 40–44
Loughran TP, Deeg HJ, Dahlberg S, Kennedy MS, Storb R, Thomas ED (1985) Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft-versus-host disease prophylaxis. Br J Haematol 59: 547–553
Ostendorf P, Ehninger G, Dopfer R, Schmidt H, Haen M, Link H, Schüch K, Müller CA, Wernet P, Klingenbiel Th, Frommhold W, Hübener K-H, Breitling G, Schneider W, Niethammer D (1986) Knochenmarktransplantation bei akuter Leukämie, chronisch myeloischer Leukämie, schwerer aplastischer Anämie und Neuroblastom Stadium IV. Einfluß antiviraler Prophylaxe mit Anti-CMV-Hyperimmunglobulin und Azyklovir. Klin Wochenschr 64: 452–466
Sanders JE (1986) Bone marrow transplantation as treatment of hematologic disease. Vox Sang 51 Suppl 2: 74–80
Storb R, Deeg HJ, Thomas ED, Appelbaum FR, Buckner CD, Cheever MA, Clift RA, Doney KC, Flournoy N, Kennedy MS, Loughran TP, McGuffin RW, Sale GE, Sanders JE, Singer JW, Stewart PS, Sullivan KM, Witherspoon RP (1985) Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease. Blood 66: 698–702
Storb R, Deeg J, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner D, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Pharm D, Thomas ED (1986) Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314: 729–735
Storb R, Epstein RB, Graham TC, Thomas ED (1970) Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts. Transplantation 9: 240–246
Tutschka PJ, Hess AD, Beschorner WE, Farmer ER, Saral R, Brookmeyer R, Santos GW (1983) Cyclosporine in clinical marrow transplantation: The Balitmore experience. Transplant Proc XV: 2613–2616
Weil C (1984) Cyclosporin A: Review of results in organ and bone-marrow transplantation in man. Med Res Rev 4: 221–265
Witherspoon RP, Deeg HJ, Lum LG, Ochs HD, Hansen JA, Thomas ED, Storb R (1984) Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease. Transplantation 37: 456–461
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, H., Ehninger, G., Dopfer, R. et al. Correlation between low CSA plasma concentration and severity of acute GvHD in bone marrow transplantation. Blut 57, 139–142 (1988). https://doi.org/10.1007/BF00320154
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320154